2021 ANCC Contact Hour Credit Attestation

Education credits (18 hours) can be obtained with an All-Access registration, by watching the live or recorded session in its entirety and completing the session survey. Please send any inquiries to darlene.seitz@myscrs.org

Date

Session Title

Credit Hour(s)

February 16, 2021

How to Manage Added Pressures and New Stress in an Already Pressurized Environment- 1:00pm-2:00pm
The SCRS Global Oncology Site Solutions Summit will open like never before. In this session, you will be treated to a mental and physical training session to help you manage stress, stay healthy, and start anew with a clear mind and physical approach to everyday.

Three Learning Objectives:

  • Learn how to use meditation as a recovery modality;
  • Learn about the importance of movement and exercise;
  • Learn about the importance of recovery (nutrition & Rest).

.50

February 16, 2021

Site Landscape: Benchmark Your Site- 2:00pm-3:00pm
Gain insight into operations and metrics to position your site for success. -Current data will be unveiled, allowing you to make an impactful change for your organization. This session has always been a favorite at the Summit, and we know you won’t be disappointed this year!

Three Learning Objectives:

  • Review of cancer facts and figures for 2021 and Covid’s Impact on Cancer.
  • Discussion about Site Financials, Study Startup and Feasibility and Partnership and Communication;
  • Discussion about Technology in Clinical Trials and the positive changes to the new technologies. 

1

February 16, 2021

Breakout Session I- Day 1- 3:15-4:15pm 
Changing the Paradigm for Staffing in Oncology Clinical Research
There is a lot of data and content out there about patient recruitment but what about staff recruitment? How can we ensure that we are attracting and acquiring the required talent to manage complex oncology trials? And then, once hired, how are we onboarding and retaining our key staff members? In this session, you’ll learn how sites and sponsors are hiring and retaining key talent to advance oncology research.

Three Learning Objectives:

  • Identify what alternatives now exist to facilitate the process of site feasibility;
  • Understand how to adjust to these innovative methods of proving “ready” for a study;
  • Learn about what continues to change and how to prepare for the future of feasibility surveys.

1

February 16, 2021

Breakout Session II- Day 1- 3:15pm-4:15pm
Case Study: Just in Time Activation for Rare Oncology Indications
In this session, you will be presented with a case study describing a partnership in Just in Time rapid activation for rare oncology indications. The presenters will cover topics including staffing, processes, efficiencies, and challenges.

Three Learning Objectives:

  • Learn what it takes for a site to do JIT;
  • Identify what a site needs to succeed;
  • Discuss the challenges to success.

 

1

February 16, 2021

Breakout Session III- Day 1- 4:30pm-5:30pm
Feasibility: What’s Changing and How to Stay Current
The process of site feasibility has and continues to evolve. What once was a process of continual submission of feasibility questionnaires — asking the same questions over and over — has become a “smart” process. We are seeing Sponsors and CROs use machine and AI learning to better track this feasibility data and better predict what sites are “best fits” for a study, and what types of sites will be needed for a study. All of this data can be used to more accurately and quickly identify and qualify sites. But at the site level, what does this mean? This session will explore the future of feasibility and what sites need to do to be prepared for this future.

Three Learning Objectives:

  • Identify what alternatives now exist to facilitate the process of site feasibility;
  • Understand how to adjust to these innovative methods of proving “ready” for a study;
  • Learn about what continues to change and how to prepare for the future of feasibility surveys.

1

February 16, 2021

Breakout Session IV- Day 1- 4:30pm-5:30pm
Study Start Up: Special Considerations for Cell and Gene Therapy
What are special startup considerations when sites are planning CAR-T or other Cell & Gene Therapy trials? Experts representing CRO, clinical coordinator, financial services, and IRB/IBC will discuss lessons learned and prospects for 2021. What are special startup considerations when sites are planning CAR-T or other Cell & Gene Therapy trials? Experts representing CRO, clinical coordinator, financial services, and IRB/IBC will discuss lessons learned and prospects for 2021.

Three Learning Objectives:

  • Identify what is required to start up a CART or other cellular therapy trial at your site;
  • Determine when IBC oversight is required for CART or other cellular therapy studies;
  • Identify what resources your research staff will need to safely conduct a CART or other cellular therapy trial. 

1

Date

Session Title

Credit Hour(s)

February 17, 2021

Oncology Clinial Trials: Trends during Pandemic and Beyond- 1:00pm-2:00pm
This panel of futurists and change agents will discuss what to expect in oncology research and what you need to be doing now to prepare. This panel of experts will prove that the tools, the systems, and the people are within your reach, but we have to find ways to get them to work better together by collaborating to bring efficiencies through partnership. Let’s listen and then find our best ways to work together for our patients now and into the future.

1

February 17, 2021

A Fireside Chat with Oncology Patients- 2:00pm-3:00pm
We will hear stories from patients of all demographics as well as those suffering from or recovering from diffferent types of cancers. This session will help us all to humanize the work we do and to emphasize why working better together will improve the patient experience.

1

February 17, 2021

Breakout Session I- Day 2- 3:15pm-4:15pm
Financial Health for Your Oncology Research
Many challenges in clinical trial financial management exist today and with some of the procedure complexities for oncology trials, budgeting and payments for those trials can come with some time-consuming planning and reconciliation. In this session, you will learn the secret to budgeting and negotiating smart for your oncology studies. In addition, we will talk through how data collection and payment triggers can allow for a smooth payment process, especially for those conditional and/or high-ticket items within your budget. Join us to connect the dots with budgeting and payments and ensure you are meeting your financial needs for your oncology trials.

Three Learning Objectives:

  • Discover best practices to ensure compliance with budget and payment term negotiations;
  • Learn about some of the hidden costs to factor into your budgets;
  • How to incorporate payment considerations into your process upfront to ensure easy reconciliation.

1

February 17, 2021

Breakout Session II- Day 2- 3:15-4:15pm
[Case Studies] Technology: Tools, Adoption, and Results
In this session, we will hear three case studies from three different companies spearheading technology advancement in oncology trials. You will learn about new types of technology, how it is being deployed, and what types of outcomes have resulted from the innovations. You will also hear how each addresses varying levels in access and understanding of new technologies. 

Three Learning Objectives:

  • Identify three examples of how sites have chosen and deployed technology in recent oncology studies;
  • Learn how these sites chose the technology and the process required to use it;
  • Discuss how the technology and the process fared in terms of adoption, execution, and results.

1

February 17, 2021

Breakout Session III- Day 2- 4:30pm-5:30pm
Physician Engagement in Oncology Research
So many varying demands on oncology investigators… so many challenges with building referral networks… so many clinical trials getting more complex… Let’s talk about ways to improve purpose-driven engagements, and move away from the transactional. Let’s talk about operational paradigms and processes that reduce an oncologist’s investigator burden. Come join our panel discussion about engaging oncologists in clinical trial work.

Three Learning Objectives:

  • Understand the varying demands for physician investigators;
  • Learn about what purpose driven interactions are and how to support them;
  • Discover community and academic investigator paradigms and needs and how to incorporate them in your studies.

 

1

February 17, 2021

Breakout Session IV- Day 2- 4:30pm-5:30pm
How Decentralized Oncology Trials are Faring in a COVID-Era
Decentralized clinical trials are those executed through telemedicine and mobile/local healthcare providers, using processes and technologies that differ from the traditional clinical trial model. In this session, learn about the technologies that are being used and the processes being followed specifically in oncology trials. Also, learn how decentralized trials have fared during the pandemic.

Three Learning Objectives:

  • Identify the technologies that are being used to conduct decentalized trials in oncology;
  • Learn about the processes being used in successfully deployed remote trials as well as pitfalls to look out for;
  • Learn about experiences of how remote trials have been used during the pandemic.

1

Date

Session Title

Credit Hour(s)

February 18, 2021

Policy and Partnerships: Initiative Updates from ACS-CAN and ASCO- 1:00pm-2:00pm
Please join this presentation for updates on some very exciting and needle-moving initiatives driven by ASCO and ACS-CAN. Through policy and partnerships we will support oncology research site sustainability and remove barriers to participation into therapeutic clinical trials for cancer.

Three Learning Objectives:

  • Gain an understanding of what workgroups are recommending to the oncology clinical trial industry;
  • Gain an understanding of what workgroups are recommending to the oncology clinical trial industry;
  • Discuss and assess the major impacts of the COVID-19 pandemic on cancer care delivery and clinical research. 

 

1

February 18, 2021

The Importance of Perspective and Well-Being during a Pandemic and When Life Takes A Turn You Don’t Expect- 2:00pm-3:00pm
In this session, we are honored to welcome Maimah Karmo, the Founder/CEO of the Tigerlily Foundation (Tigerlily) and a 14-year survivor of breast cancer. Maimah will share her story as a cancer survivor and also how she has coped with life during the pandemic.

Three Learning Objectives:

  • Learn about breast health, educational, empowerment wellness and transformational programs to young women;
  • Learn about the launching of national and global health initiatives focused on ending disparities;
  • Learn about the Protecting Access to Lifesaving Screening (PALS) legislation.

 

1

February 18, 2021

Breakout Session I- Day 3- 3:15pm-4:15pm
Oncology and the Impact of COVID-19
The COVID-19 pandemic has changed clinical research forever. As a result, sites have had to adopt new technologies, train and coach staff, implement new processes, and create an entirely new model of conducting studies. Communicating these changes and new capabilities to sponsors, CROs and patients is essential for ongoing as well as new study opportunities. This session will explore successes, challenges, and how to be prepared.

Three Learning Objectives:

  • Discuss how the pandemic has affected how we perform clinical trials;
  • Identify examples of how to communicate with sponsors/CROs regarding remote monitoring and risk-based monitoring procedures;
  • Describe a plan and rationale for communicating to patients your site’s visit options and safety precautions during a crisis.

1

February 18, 2021

Breakout Session II- Day 3- 3:15pm-4:15pm
Access of Right Treatments to the Right Patients in Oncology
How Use of AI and Digital Health Solutions Enables Democratization of Access to Oncology Clinical Trials and How COVID Influences this New Normal?
Oncology Clinical Trial enrollment rates stalled to single digits over decades and with the addition of COVID, healthcare systems have been significantly stressed to enroll patients to clinical trials – almost every clinical trial is late in terms of enrollment targets. While issues have been exacerbated by COVID, a world of new opportunities have arisen to improve access to clinical trials that may not have been considered as must have in pre-COVID era such as incorporation of telemedicine and virtual visits to receive consent or taking pre-screening outside the site with technology. The audience will be able to learn about the challenges of sites in oncology clinical enrollment – before and after COVID. Further we will discuss how the use of AI and digital health solutions improve the enrollment and access to oncology clinical trials and how innovations are getting adopted at scale at a rapid pace.

Three Learning Objectives:

  • Understand how COVID-19 impacted Sponsor’s oncology clinical trial enrollment plans and best practices to mitigate risk of COVID-19;
  • Understand how Sponsors leverage AI and digital health solutions in oncology trial enrollment and the implication to sites;
  • Understand how oncology clinical trial enrollment will evolve in the next 5 years and the largest barriers for growth.

1

February 18, 2021

Breakout Session III- Day 3- 4:30pm-5:30pm
Diversity in Oncology Clinical Trials
The lack of comprehensive data in oncology clinical trials limits the benefits to a largely white patient population. Further, minorities who are diagnosed with cancer often have the lowest survival rates for most types of the disease. In this session, we’ll discuss how sites are trying to expand the patient populations to reach subpopulations, collect critical data, and save more lives.

Three Learning Objectives:

  • Discuss building trust through Community Outreach;
  • Learn about changing HR practices / hiring clinical research staff sequirement;
  • Discuss Informed Consent Process.
 

1

Date

Session Title

Credit Hour(s)

February 23, 2021

Oncology NOW: What’s Impacting Oncology Sites in 2021- 11:30-1:00pm
Oncology clinical trials have not been spared the challenges associated with the resulting changes that 2020 has brought. SCRS’s SitesNOW programming brings our industry partners and sites together to learn about and discuss those challenges, coming away with some key learnings that we can all work towards going forward. Sandy Smith, the incumbent Chair of the SCRS Oncology Program will kick the session off with an introduction on the state and future of oncology trials, leading into the attendees breaking out into teams to address and tackle important questions and coming up with those key learnings. 

Three Learning Objectives:

  • Discuss current state of Oncology;
  • Discuss the impact of the Pandemic;
  • Discuss the outlook, trends and strategies to achieve equity in cancer research.

1.5

TOTAL CREDIT HOURS

18

REGISTER NOW